Mutuum Finance (MUTM) has officially confirmed a major step in its roadmap with the activation of its V1 protocol on the Sepolia testnet.
Highlights: First participant enrolled and dosed with NUZ-001 in Regimen I of the HEALEY ALS Platform Trial evaluating ...
Follow live updates and the latest news coverage as the U.S. and Israel continues to strike Iran and Tehran hits back across ...
The first participant has been dosed in Regimen I of the HEALEY ALS Platform Trial evaluating Neurizon Therapeutics’ lead candidate NUZ-001 for the treatment of amyotrophic lateral sclerosis (ALS).
Founded by Dr. Dorra Frikha, a PhD-trained scientist in bone mechanics, DKGlow is a biotech-driven skincare brand rooted in mitochondrial research.
Clinical trials can vary in length depending on several factors. Here's what you need to know about how long clinical trials last.
This complete playbook covers architecture decisions, enrollment UX, recovery design, and the deployment strategies that drove eBay's 102% adoption increase and HubSpot's 4x faster logins.
Dosing has begun in a new regimen of the HEALEY ALS platform trial, its ninth, which is testing the oral therapy NUZ-001 for ...
The Phantom MK-1 looks the part of an AI soldier. Encased in jet black steel with a tinted glass visor, it conjures a visceral dread far beyond what may be evoked by your typical humanoid robot. And ...
Flow Foundation is taking a series of concrete actions to strengthen FLOW, with three initiatives: a token buyback & burn, continuous token acquisition with structural improvements to liquidity, and ...
Panel recap on building institutional crypto rails for digital assets. Leaders from Mirae, Kyobo, Futu, Solana, and AWS discuss custody, regulation, and market maturity signals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results